Literature DB >> 21467273

Management of sepsis: a 47-year-old woman with an indwelling intravenous catheter and sepsis.

Derek C Angus1.   

Abstract

Severe sepsis is the term used to describe the host response to infection when complicated by acute organ dysfunction. Severe sepsis occurs in more than 750,000 individuals in the United States each year, with a hospital mortality of about 30%. Although the classic presentation is of florid shock with frank hypotension, fever, and elevated white blood cell count, many patients can present with cryptogenic shock (shock without hypotension) with more subtle signs of vital organ compromise. Using the case of Ms C, a 47-year-old woman with short gut syndrome and an indwelling intravenous catheter who developed an episode of severe sepsis secondary to a central line infection, treatment of sepsis is discussed. Management consists of prompt intervention with broad-spectrum antibiotics and fluid resuscitation, even in the absence of hypotension, and institution of a variety of strategies in the emergency setting to prevent development or worsening of vital organ dysfunction. Although advances in understanding the host immune response have fueled considerable interest in immunomodulatory therapy, the role of such agents in clinical practice remains limited and controversial.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467273     DOI: 10.1001/jama.2011.438

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  10 in total

1.  Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.

Authors:  Joseph D Lutgring; Cassiana Bittencourt; Erin McElvania TeKippe; Dominick Cavuoti; Rita Hollaway; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Immunosuppression in patients who die of sepsis and multiple organ failure.

Authors:  Jonathan S Boomer; Kathleen To; Kathy C Chang; Osamu Takasu; Dale F Osborne; Andrew H Walton; Traci L Bricker; Stephen D Jarman; Daniel Kreisel; Alexander S Krupnick; Anil Srivastava; Paul E Swanson; Jonathan M Green; Richard S Hotchkiss
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

3.  Depressive symptoms in spouses of older patients with severe sepsis.

Authors:  Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Theodore J Iwashyna
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

Review 4.  Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis.

Authors:  Lin Ouyang; You-Di Lv; Can Hou; Guo-Bao Wu; Zhi-Hui He
Journal:  Mol Biol Rep       Date:  2013-05-29       Impact factor: 2.316

5.  Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Authors:  Theodore J Iwashyna; Andrew Odden; Jeffrey Rohde; Catherine Bonham; Latoya Kuhn; Preeti Malani; Lena Chen; Scott Flanders
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

6.  Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation.

Authors:  Sean E Gill; Claudia C Dos Santos; David B O'Gorman; David E Carter; Eric K Patterson; Marat Slessarev; Claudio Martin; Mark Daley; Michael R Miller; Gediminas Cepinskas; Douglas D Fraser
Journal:  Intensive Care Med Exp       Date:  2020-12-11

7.  Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein.

Authors:  Ji-Ding Fu; Chun-Hui Gao; Shi-Wei Li; Yan Tian; Shi-Cheng Li; Yi-Er Wei; Le-Wu Xian
Journal:  Acta Cir Bras       Date:  2021-10-08       Impact factor: 1.388

8.  Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans.

Authors:  Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Theodore J Iwashyna
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

9.  The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis.

Authors:  Hui-Chen Lo; Ching-Yi Hung; Fu-Huan Huang; Tzu-Cheng Su; Chien-Hsing Lee
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

10.  Distribution and drug resistance of pathogenic bacteria in emergency patients.

Authors:  Wei Huai; Qing-Bian Ma; Jia-Jia Zheng; Yang Zhao; Qiang-Rong Zhai
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.